• |
    LogoImage2-AUCD

    AUCD Community Inclusion

    AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

  • |
    LogoImage2-AUCD

    AUCD Maternal and Child Health Engagement

    AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

  • |
    LogoImage2-AUCD

    AUCD Public Health

    AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

  • |
    LogoImage2-AUCD

    AUCD Emerging Leaders Community

    AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.  

Donate

AUCD Experts

Daniel Coury, MD

Login to Update Your Profile
Center:
OH-The Nisonger Center, UCEDD/LEND
Contact Information:
321 McCampbell Hall 1581 Dodd Drive, Columbus, OH, 43210
614-292-6816
Leadership:
Discipline Coordinators:
Discipline(s):
AUCD Council Membership:
Vita/Bio:
Service:
Linked Projects
Leadership Education Excellence in Neurodevelopmental Disabilities
Leadership Education Excellence in Neurodevelopmental Disabilities
Healthy Tomorrows Rural Developmental Clinic Initiative
Healthy Tomorrows Rural Developmental Clinic Initiative
Leadership Education Excellence in Neurodevelopmental Disabilities
A 5-week, Multi-center, Multi-center, Double-blind, Study of Dexmethylphenidate HCL (Focalin XR) Administered Once Daily in Pediatric Patients
A Phase III, Randomized, Multi-Center, Double-Blind, Parallel-Group, Placebo-ControlledStudy of NRP104 in Children Aged 6-12 Years with ADHD
A Two-Year, Open-Label, Single-Arm Study of NRP104 30 mg, 50 mg, or 70 mg per Day in Children Ages 6-12 with ADHD
Phase III, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study of Adderall XR with Open-Label Extension in Adolescents 13-17 with ADHD
A Phase III, Open-Label Study of SPD503 in Children and Adolescents Aged 6-17 with Attention-Deficit Hyperactivity Disorder (ADHD)
Maintenance of Benefit after 8-Week and 52-Week Treatment with Atomoxetine Hydrochloride in Adolescents with Attention Deficit Hyperactivity Disorder
Phase III, Multi-center, 18-month, Open-Label Study of Adderall XR in the Treatment of Adolescents with ADHD
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Pharmaceutical Efficacy of Focalin LA in Children Aged 6-17 with ADHD
Evaluation of Continuous Symptom Treatment of ADHD: A Placebo-Controlled Double-Blind Assessment of Morning-Dosed or Evening-Dosed Strattera
A Randomized, Multi-Center, Double-Blind, Parallel-Group, Placebo-Controlled Safety & Efficacy Study of Adderall XR in Adolescents 13-17 with ADHD
Open, Randomized, Multicenter Study of Frozen MMRV Given Concomitantly Versus Nonconcomitantly in Healthy Children 12 to 15 Months of Age
Phase II Randomized, Controlled Study of Two Combination Vaccines Containing Meningococcal C and Pneumococcal Capsular
A Six-Month Open-Labeled Study of SLI381 in Children with Attention Deficit Hyperactivity Disorder
A Phase III, 3 Open-Label, Long-Term, Safety and Efficacy Study of Atmoxetine
A Study of M-M-R II at Mumps Expiry Potency in Healthy Children 12 to 18 months of Age
MCH Interdisciplinary Training Program
2 - Core Funding: LEND - Leadership Education Excellence in Neurodevelopmental Disabilities
LEND - Hospital Based Regional Child Find Coordination
LEND - Maternal Depression Project
Linked Products
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficie/hyperactivity disorder
Safety and Immunogenicity of a Measles, Mumps, Rubella adn Diphtheria/Tetanus/Acellular Pertussis Vaccines
Over the Rainbow: Advancing Child Health in the New Millennium
Single Dose Pharmacokinetic evaluation of Three Different Dose Levels of Zolpidem in Children with Sleep Difficulties
Resident Training in Developmental/Behavioral Pediatrics. Where do we stand?
Footer-Logo-AUCD

1100 Wayne Avenue, Suite 1000 Silver Spring, MD 20910

Copyright 2025 Association of University Centers on Disabilities

  • AUCD Federal Partners
Subscribe to AUCD’s Newsletter

Copyright 2025 Association of University Centers on Disabilities